2024-04-16 18:04:57 ET
Summary
- Transcat, Inc.'s business has seen significant growth of its well-positioned calibration services and equipment, with organic growth being complemented by bolt-on dealmaking.
- The company relies on the life science industry for 60% of its sales, warranting a premium multiple, and it just announced an acquisition.
- Despite strong growth, valuations are high, and management has been selling shares to shore up the balance sheet as well as to take some profits themselves.
Shares of Transcat, Inc. ( TRNS ) have been on fire lately as investors have grown more appreciative of this calibration service and equipment provider. Perhaps investors have extrapolated growth prospects and stability a bit too much, as valuations have become quite demanding....
Read the full article on Seeking Alpha
For further details see:
Transcat Stock: Time To Recalibrate